用于癌症免疫治疗的反瘤免疫抑制微环境的纳米LYTAC
Mengke Xu1, Yuxuan Hu1, Jiayan Wu1
1School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457.
Journal of the American Chemical Society
|December 7, 2024
概括
一种针对纳米基因组的新型基因组 (纳米-LYTAC) 可降解免疫抑制的M2巨细胞并增强癌症免疫疗法. 这种方法对瘤微环境进行重新编程,从而抑制瘤生长和在临床前模型中的转移.
科学领域:
- 生物医学工程
- 癌症研究
- 免疫疗法
背景情况:
- 细胞外和膜外蛋白显著影响瘤免疫抑制微环境 (TIME).
- 蛋白质降解疗法主要针对癌细胞,在TIME内对免疫细胞的应用有限.
研究的目的:
- 开发用于M2巨细胞膜蛋白降解和声动力学治疗的聚合物纳米基因组向基因组 (纳米-LYTAC).
- 评估纳米LYTAC在重新编程时间和增强组合癌症免疫疗法的有效性.
主要方法:
- 开发一个聚合物纳米解体向仿真体 (纳米-LYTAC).
- 对纳米-LYTAC对白蛋白4受体 (IL-4R) 的降解效果及其对M2巨细胞功能 (CD206表达,IL-10分泌,细胞亡) 的度依赖性影响的评估.
- 在临床前癌症模型中评估纳米-LYTAC的瘤保留及其对TIME组件 (M2巨细胞,调节性T细胞,树突细胞,T效应细胞) 的影响.
主要成果:
- 与传统的抑制剂相比,纳米LYTAC显示出较高的IL-4R降解.
- 低度的纳米LYTAC降低了M2巨细胞的CD206表达和IL-10分泌,而高度则诱导了亡.
- 纳米LYTAC显示出长时间的瘤保留 (> 48小时),使得有效的声动力免疫疗法能够抑制瘤生长,转移和复发.
结论:
- 纳米LYTAC作为一个有效的平台,用于M2巨的向和声动疗法.
- 这种方法协同重编程瘤免疫抑制微环境,促进抗瘤免疫力.
- 纳米LYTAC对先进的组合癌症免疫疗法具有前景.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
15.9K
相关概念视频
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:30Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338